INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual P&L / Income Statement

INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual P&L / Income Statement

Income statement for 2025-07-01 through 2026-06-30. View: Business segment. Revenue and costs use their disclosed categories.

Sales, net

43,872,000 US dollars

Cost of sales

43,072,000 US dollars

Gross profit

800,000 US dollars

Operating expenses (calculated)

3,505,000 US dollars

Operating (loss) income

negative 2,705,000 US dollars

Total other income, net

142,000 US dollars

(Loss) income before income taxes

negative 2,563,000 US dollars

Income tax expense, net

279,000 US dollars

Net (loss) income

negative 2,842,000 US dollars

Contract Manufacturing revenue

42,388,000 US dollars

Other Nutraceutical Business revenue

1,484,000 US dollars

Contract Manufacturing cost of revenue

41,514,000 US dollars

Other Nutraceutical Business cost of revenue

1,558,000 US dollars

Selling and administrative expenses

3,505,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.